US 12371434
MLL1 inhibitors and anti-cancer agents
granted A61KA61K31/437A61K31/52
Quick answer
US patent 12371434 (MLL1 inhibitors and anti-cancer agents) held by CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH CO., LTD. expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH CO., LTD.
- Grant date
- Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/437, A61K31/52, A61K31/53, A61K45/06